Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer

被引:23
|
作者
Inamori, Koji [1 ,2 ,3 ,4 ,5 ]
Togashi, Yosuke [1 ]
Fukuoka, Shota [1 ]
Akagi, Kiwamu [6 ]
Ogasawara, Kouetsu [7 ]
Irie, Takuma [1 ]
Motooka, Daisuke [8 ]
Kobayashi, Yoichi [9 ,10 ]
Sugiyama, Daisuke [9 ]
Kojima, Motohiro [11 ]
Shiiya, Norihiko [3 ,4 ,5 ]
Nakamura, Shota [8 ]
Maruyama, Shoichi [10 ]
Suzuki, Yutaka [12 ]
Ito, Masaaki [2 ]
Nishikawa, Hiroyoshi [1 ,9 ]
机构
[1] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr EPOC, Div Canc Immunol, Res Inst, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[2] Natl Canc Ctr Hosp East NCCHE, Dept Colorectal Surg, Chiba, Japan
[3] Hamamatsu Univ, Div Cardiovasc, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ, Div Thorac, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[5] Hamamatsu Univ, Div Gen Endoscop & Breast Surg, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[6] Saitama Canc Ctr SCC, Div Mol Diag & Canc Prevent, Saitama, Japan
[7] Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Sendai, Miyagi, Japan
[8] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan
[9] Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi, Japan
[10] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Aichi, Japan
[11] NCCHE, Div Pathol, Chiba, Japan
[12] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan
关键词
REGULATORY T-CELLS; MICROSATELLITE INSTABILITY; PD-1; BLOCKADE; CLINICOPATHOLOGICAL FEATURES; EXPRESSION; TUMORS; COLON; INFILTRATION; MULTICENTER; IMMUNOLOGY;
D O I
10.1172/jci.insight.137365
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Patients with colorectal cancers (CRCs) generally exhibit improved survival through intensive lymph node (LN) dissection. However, recent progress in cancer immunotherapy revisits the potential importance of regional LNs, where T cells are primed to attack tumor cells. To elucidate the role of regional LN, we investigated the immunological status of nonmetastatic regional LN lymphocytes (LNLs) in comparison with those of the tumor microenvironment (tumor-infiltrating lymphocytes; TILs) using flow cytometry and next-generation sequencing. LNLs comprised an intermediate level of the effector T cell population between peripheral blood lymphocytes (PBLs) and TILs. Significant overlap of the T cell receptor (TCR) repertoire was observed in microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) CRCs with high tumor mutation burden (TMB), although limited TCRs were shared between nonmetastatic LNs and primary tumors in microsatellite stable/MMR proficient (MSS/pMMR) CRC patients with low TMB. In line with the overlap of the TCR repertoire, an excessive LN dissection did not provide a positive impact on long-term prognosis in our MSI-H/dMMR CRC cohort (n = 130). We propose that regional LNs play an important role in antitumor immunity, particularly in MSI-H/dMMR CRCs with high TMB, requiring care to be taken regarding excessive nonmetastatic LN dissection in MSI-H/dMMR CRC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Neoadjuvant Immunotherapy Alone for Patients With Locally Advanced and Resectable Metastatic Colorectal Cancer of dMMR/MSI-H Status
    Li, Yingjie
    Tan, Luxin
    Chen, Nan
    Liu, Xinzhi
    Liang, Fei
    Yao, Yunfeng
    Zhang, Xiaoyan
    Wu, Aiwen
    DISEASES OF THE COLON & RECTUM, 2024, 67 (11) : 1413 - 1422
  • [32] Natural history and patterns of progression for dMMR/MSI-H colorectal cancer treated with immune checkpoint blockade: A single center retrospective analysis.
    Higbie, Victoria
    Shah, Preksha
    Bent, Alisha Heather
    Dasari, Arvind
    Huey, Ryan W.
    Johnson, Benny
    Kee, Bryan K.
    Kopetz, Scott
    Lee, Michael Sangmin
    Ludford, Kaysia
    Morelli, Maria Pia
    Morris, Van K.
    Parseghian, Christine Megerdichian
    Raghav, Kanwal Pratap Singh
    Shen, John Paul Y. C.
    Willis, Jason
    Wolff, Robert A.
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 145 - 145
  • [33] Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience
    Higbie, Victoria Serpas
    Rogers, Jane
    Hwang, Hyunsoo
    Qiao, Wei
    Xiao, Lianchun
    Dasari, Arvind
    Mola-Rudd, Kerri
    Morris, Van K.
    Wolff, Robert A.
    Raghav, Kanwal
    Huey, Ryan
    Parseghian, Christine
    Willis, Jason
    Kopetz, Scott
    Overman, Michael J.
    Johnson, Benny
    ONCOLOGIST, 2022, 27 (11): : 952 - 957
  • [34] Analysis of HLA gene expression in patients with dMMR/MSI-H colorectal carcinoma resistant to immune checkpoint inhibitors.
    Lenz, Heinz-Josef
    Nicolaides, Theodore
    Elliott, Andrew
    Goldberg, Richard M.
    Marshall, John
    Lou, Emil
    Shields, Anthony Frank
    Sohal, Davendra
    Weinberg, Benjamin Adam
    Spetzler, David
    Abraham, Jim
    Xiu, Joanne
    Korn, Wolfgang Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 202 - 202
  • [35] Management of MSI-H/dMMR Upper and Lower Gastrointestinal Cancers
    Ajani, Jaffer A.
    Pedersen, Katrina S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22
  • [36] Genomic evolutionary mechanisms in MSI-H colorectal cancer
    Kobayashi, Yuta
    Niida, Atsushi
    Haeno, Hiroshi
    Masuda, Takaaki
    Doki, Yuichiro
    Eguchi, Hidetoshi
    Shibata, Tatsuhiro
    Mimori, Koshi
    CANCER SCIENCE, 2025, 116 : 775 - 775
  • [37] Neoadjuvant pembrolizumab for localized solid MSI-H/dMMR tumors
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (10):
  • [38] Nivolumab plus ipilimumab for MSI-H colorectal cancer
    不详
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (02): : 112 - 112
  • [39] Safety and efficacy of pembrolizumab monotherapy in patients with advanced colorectal MSI-h/dMMR cancers.
    Michalaki, Vasiliki
    Polydorou, Andreas
    Dafnios, Nikolaos
    Theodosopoulos, Theodosios
    Vezakis, Antonios
    Iliakopoulos, Konstantinos
    Karandrea, Despina
    Papadimitriou, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Prognostic role of systemic inflammatory markers in patients with metastatic MSI-h/dMMR colorectal cancer receiving immunotherapy.
    Bhamidipati, Deepak
    Raghav, Kanwal Pratap Singh
    Morris, Van K.
    Kopetz, Scott
    Kee, Bryan K.
    Johnson, Benny
    Willis, Jason
    Dasari, Arvind
    Morelli, Maria Pia
    Parseghian, Christine Megerdichian
    Lee, Michael Sangmin
    Le, Phat
    Shen, John Paul Y. C.
    Ludford, Kaysia
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)